TMX Newsfile·2026-03-07 13:13Core Viewpoint - A class action lawsuit has been filed against Boston Scientific Corporation for allegedly making misleading statements regarding its U.S. Electrophysiology segment, leading to investor losses during the Class Period from July 23, 2025, to February 3, 2026 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that during the Class Period, Boston Scientific's management made positive statements while concealing material adverse facts about the sustainability of the growth rate in its U.S. Electrophysiology segment [5]. - Investors were reportedly surprised by Boston Scientific's net income miss and underwhelming guidance for the first half of fiscal 2026, which the lawsuit attributes to the misleading statements made by the defendants [5]. Group 2: Participation Information - Investors who purchased Boston Scientific common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm, which is leading the class action, has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 [4]. - The firm has been recognized for its success in securities class action settlements and has consistently ranked among the top firms in this area since 2013 [4].